Nurullah Akkoç1, Handan Yarkan2, Gökçe Kenar2, Muhammad A Khan3. 1. , Izmir, Turkey. nurullah.akkoc@gmail.com. 2. Department of Rheumatology, Faculty of Medicine, Dokuz Eylul University, Balcova, 35340, Izmir, Turkey. 3. MetroHealth Medical Center, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH, 44109, USA.
Abstract
PURPOSE OF REVIEW: We review our current knowledge about the clinical features of patients with ankylosing spondylitis (AS) who possess HLA-B*27 versus those who lack this gene. RECENT FINDINGS: ERAP1 association is present only in HLA-B*27+ patients, but other genetic associations are similar between the two groups. A genetic study supports the existence of an HLA-B27-independent common link between gut inflammation and AS. It is unusual to observe familial occurrence of primary AS among families of northern European extraction that show no segregation of HLA-B*27, psoriasis, or IBD. Although there are many similarities among AS patients possessing HLA-B*27 versus those lacking this gene, the former group has a younger age of onset, a shorter delay in diagnosis, a better clinical response to tumor necrosis factor inhibitors, a greater familial occurrence, a greater risk for occurrence of acute anterior uveitis, and a lower risk for occurrence of psoriasis and IBD. ERAP1 association is present only in HLA-B*27+ patients, but other genetic associations are similar between the two groups. It is unusual to observe occurrence of primary AS among families of northern European extraction that show no segregation of HLA-B*27, IBD, or psoriasis. A recent genetic study supports the existence of an HLA-B*27-independent common link between gut inflammation and AS.
PURPOSE OF REVIEW: We review our current knowledge about the clinical features of patients with ankylosing spondylitis (AS) who possess HLA-B*27 versus those who lack this gene. RECENT FINDINGS:ERAP1 association is present only in HLA-B*27+ patients, but other genetic associations are similar between the two groups. A genetic study supports the existence of an HLA-B27-independent common link between gut inflammation and AS. It is unusual to observe familial occurrence of primary AS among families of northern European extraction that show no segregation of HLA-B*27, psoriasis, or IBD. Although there are many similarities among AS patients possessing HLA-B*27 versus those lacking this gene, the former group has a younger age of onset, a shorter delay in diagnosis, a better clinical response to tumor necrosis factor inhibitors, a greater familial occurrence, a greater risk for occurrence of acute anterior uveitis, and a lower risk for occurrence of psoriasis and IBD. ERAP1 association is present only in HLA-B*27+ patients, but other genetic associations are similar between the two groups. It is unusual to observe occurrence of primary AS among families of northern European extraction that show no segregation of HLA-B*27, IBD, or psoriasis. A recent genetic study supports the existence of an HLA-B*27-independent common link between gut inflammation and AS.
Authors: Jürgen Braun; Martin Rudwaleit; Sonja Kary; Martina Kron; Robert L Wong; Hartmut Kupper Journal: Rheumatology (Oxford) Date: 2010-05-06 Impact factor: 7.580
Authors: Maxime Dougados; Maria-Antonietta d'Agostino; Joëlle Benessiano; Francis Berenbaum; Maxime Breban; Pascal Claudepierre; Bernard Combe; Patricia Dargent-Molina; Jean-Pierre Daurès; Bruno Fautrel; Antoine Feydy; Philippe Goupille; Véronique Leblanc; Isabelle Logeart; Thao Pham; Pascal Richette; Christian Roux; Martin Rudwaleit; Alain Saraux; Jean-Marc Treluyer; Désirée van der Heijde; Daniel Wendling Journal: Joint Bone Spine Date: 2011-03-31 Impact factor: 4.929
Authors: M Yang; M Xu; X Pan; Z Hu; Q Li; Y Wei; Y Zhang; J Rong; J Zhai; P He; S Hu; H Song; H Wu; F Zhan; S Liu; G Gao; Z Liu; Y Li; L Shen; A Huang; Z Lin; Z Liao; S Cao; Q Wei; Q Li; Q Lv; J Qi; T Li; O Jin; Y Pan; J Gu Journal: Tissue Antigens Date: 2013-11
Authors: Miranda van Lunteren; Désirée van der Heijde; Alexandre Sepriano; Inger J Berg; Maxime Dougados; Laure Gossec; Lennart Jacobsson; Roberta Ramonda; Martin Rudwaleit; Joachim Sieper; Robert Landewé; Floris A van Gaalen Journal: Rheumatology (Oxford) Date: 2019-09-01 Impact factor: 7.580